Corporate Venture Capital: Designing a CVC for Strategic Return

Corporates are now central to venture capital. McKinsey reported in 2022 that large companies are involved in about a third of all venture deals, an all-time high. CB Insights recorded global CVC-backed funding falling 43% from $173.8B in 2021 to $98.9B in 2022, which was still the second-strongest year on record. Global Corporate Venturing's tracking shows corporate investors rising from 721 in 2014 to 2,909 in 2021, and it reports that 2025 was a record year for CVCs, with more than 3,000 corporations making at least one minority investment in a startup in the past year. It also notes that keeping a unit going beyond its first three years is a much bigger feat than launching one. Corporate capital is sizeable and cyclical. Yet being present is not the same as being effective.

The effectiveness gap is documented. McKinsey's study found that only 14% of incumbents that invest in young companies have adopted the practices needed to create lasting value, and that more than 70% of CVC activity is sporadic or opportunistic. Startups report that only about one in ten of their corporate partnerships succeeds. Top-tier innovators, by contrast, captured between two and three times the economic profit from these deals than their competitors. The difference is not luck. It is design.

For a head of strategy, the question is not whether to have a venture arm, but how to build one that behaves as a strategic capability rather than a collection of investments. A programme that is sporadic, opportunistic and disconnected from the operating businesses will produce a portfolio of stakes and little else. It will also be the first target when cost pressure rises, as the contraction in 2022 showed. Durable programmes are those the business units use and the board understands.

Before launching or relaunching, write a one-page statement of strategic intent: which problems the corporation needs startups to help solve, which business units will use them, and what the corporation would be unwilling to invest in. Test the statement with three business-unit leaders. If they cannot name the startups they would want to work with, the programme has not yet earned its mandate. Resolve that before raising a fund or hiring a team.

Context also matters. Corporate venturing tends to expand when balance sheets are strong and shrink when cost pressure rises, which is why the 2022 contraction hit so many programmes at once. Boards remember the retrenchment. A programme that can show a handful of business outcomes, such as customers won, costs saved or capabilities acquired, will survive a downturn; one that can only show a portfolio of stakes at cost will be asked why it should continue. Build the evidence base from the first year.

The latest data show a more selective corporate investor. CB Insights reported that global CVC deal volume fell 13% quarter on quarter to 728 deals in Q1 2025, the lowest quarterly total since Q1 2018, and that CVC-backed funding fell 22% to $18.7B. The median CVC-backed deal size rose to $10M from $8.9M in full-year 2024. Corporates are writing fewer, larger cheques.

Concentration is marked. US startups captured 70% of global CVC-backed funding in Q1 2025, and AI startups secured seven of the top ten CVC deals. Early-stage investments made up 65% of CVC deals, and mega-rounds of $100M+ accounted for 59% of CVC-backed funding. Regional patterns differ: Asia leads with 39% of early-stage CVC deals, compared with 33% in the US and 21% in Europe. The median US deal reached $17M, over 50% more than Europe at $10.9M, while the median early-stage deal was $5.8M.

This matters to corporate strategists in three ways. First, competition for the best early-stage companies is intense and concentrated, so a small corporate fund without a distinctive offer will struggle to win allocation. Second, AI is absorbing a large share of the biggest rounds, which raises valuations and limits reasonably priced entry points. Third, regional differences in stage and cheque size mean a European or Gulf programme should not copy a Silicon Valley playbook. Know what you can offer that a financial fund cannot.

Be specific about the offer. A corporate can provide customers, data, distribution, technical validation and regulatory knowledge that financial investors cannot. Decide which two or three of these you will lead with, and make sure the business units can deliver them. Then set an entry strategy by stage and region: where you will lead, where you will follow, and where you will invest only alongside a recognised fund. Writing these rules down early prevents drift towards whatever is fashionable.

There is also a question of timing and patience. Corporate investors that follow rounds led by financial funds benefit from external validation but pay full prices and arrive late. Those that lead early rounds gain influence and pricing advantage but need real technical judgement and a willingness to be wrong. Neither approach is superior. What matters is that the choice is deliberate and matches the programme's resources. A small team with no technical depth should not try to lead early rounds in unfamiliar fields.

McKinsey's survey exposed a gap between rhetoric and motive. Of the corporate respondents, 75% were motivated by the desire to gain market insights, while just 15% cited the opportunity to use CVC as a way to make money. On the startup side, 40% sought access to distribution channels and 25% help with branding. Corporates mainly want learning and access, and startups want customers and credibility, a more promising basis for partnership than financial return.

Yet most programmes are measured as if they were funds. In Global Corporate Venturing's 2022 survey, 74% of CVCs relied on standard venture financial metrics such as IRR, 48% on exits and 32% on distributions to paid-in capital. Half rated financial returns as a top priority and 75% as very important. At the same time, 84% gave the highest scores to strategic insight on emerging technology, while culture change (23%) and corporate brand enhancement (19%) were rated less highly.

The result is a built-in conflict. A CVC funded for strategic reasons but scored on IRR will behave like a mediocre fund; one scored on strategy alone will drift without discipline. Neither the board nor the business units will see what they were promised. The head of strategy should insist on a single primary objective, a secondary objective that is explicitly subordinate, and a small scorecard that reflects both. Financial discipline protects the programme's credibility; strategic metrics protect its purpose.

Draft a balanced scorecard of no more than eight measures. On the financial side: portfolio value against cost, realised exits and follow-on rates. On the strategic side: commercial pilots started, the share of portfolio companies in active business-unit relationships, insight reports used in decisions, and acquisitions or licences considered. Agree thresholds in advance, and review them with the CEO twice a year. Treat the scorecard as a design document: if you cannot score it, the programme is not yet clear.

Another useful discipline is to distinguish learning value from commercial value. Some investments are worth holding for the insight they provide even when no deal with a business unit is possible. Others should be justified only by the prospect of a contract or an acquisition. Labelling each investment on the way in, and reviewing the label annually, stops the programme using insight as a universal defence for poor commercial outcomes, while still allowing genuinely valuable learning to be counted fairly.

McKinsey found that 40% of corporations reporting a high measurable impact from their CVC efforts have the unit report directly to the CEO, and that half of the high-impact programmes were, by design, independent from their business units. Global Corporate Venturing's survey shows reporting lines vary: heads of venturing most often report to the chief executive (25%), the head of strategy (18%), the CFO (17%) or the head of corporate development (15%).

These findings point to a deliberate tension. Independence from business units gives the CVC speed, the credibility to invest in startups that threaten existing lines, and protection from short-term pressures. Proximity to the CEO gives it authority, stable funding and access to the whole company. Yet independence without connection creates the portfolio problem: investments that nobody in the business uses. The design challenge is to separate decision rights from adoption rights. The CVC decides what to invest in; business units decide what to adopt.

In practice, this suggests a CVC with an investment committee that includes the CEO or CFO and two or three senior business-unit leaders, where the decision rests with the committee rather than any one unit. It also suggests clear conflict rules: who sees which confidential information, and when a business unit may negotiate with a portfolio company. Without these, startups will hesitate to share data, and business units will avoid engaging for fear of leaking competitive plans.

Write the charter before the first deal. It should state the mandate, investment criteria, committee composition, information barriers, approval limits and stop rules. Appoint a business-unit liaison for each priority area, with time allocated and an objective tied to their own performance. Review the charter annually. The aim is a structure simple enough to explain on one page and robust enough to survive a change of chief executive.

Information handling deserves particular care. A corporate investor that sits on a startup's board while its business unit negotiates a supply contract creates an obvious conflict. Rules about who sees what, how board observers are chosen and when a recusal is required should be settled before a deal, and shared with the startup. Founders talk to one another, and a reputation for fair treatment is a competitive asset in winning allocations against financial funds that offer nothing but capital.

The central weakness in most programmes is the gap between investment and adoption. McKinsey found that startups report a discouraging one-in-ten success rate with CVC partnerships, that at least a third of corporations struggled to establish the right fast-track procurement process, and that about a third report having no plans to expand their existing partnerships to other parts of their business. Over a third of the startups surveyed feel corporate innovation teams lack the authority or budgets to move projects forward.

These are operating problems, not investment problems. A startup that wins a pilot but cannot get through procurement, security review and a business-unit budget cycle quickly will lose momentum, and its investor will lose patience. Meanwhile the business unit, uncertain about the startup's longevity, hedges by building in-house. The portfolio company and the corporate each conclude the other is slow. Neither is wrong, and the CVC sits between them with no authority to resolve it. Global Corporate Venturing found that almost half (49%) of CVCs practise venture clienting, in which teams focus on becoming customers of startups, a model that puts the commercial pathway at the centre of the programme.

This is the core of our position. A CVC without a commercial pathway into business units is an expensive portfolio, not a strategy. The pathway needs explicit design: a named sponsor in each business unit, a fast-track route through procurement and security, a pilot budget that does not compete with the unit's operating budget, and a decision date by which the pilot becomes a contract or ends. The CEO must sponsor these mechanisms, because only the CEO can change how the corporation buys.

Map the journey from first meeting to commercial contract for the last three startup relationships your company had, noting the elapsed time at each stage. The bottlenecks will be visible within an hour. Fix the two worst, usually procurement and security review, before making the next investment. Then agree a service level with business units: for example, that every portfolio company receives a structured introduction within a month and a decision on a pilot within a quarter.

It helps to track the pathway with a few simple measures: the number of days from first introduction to a signed pilot, the share of pilots that convert to contracts, and the proportion of portfolio companies with a named business-unit sponsor. These measures expose the real bottleneck far earlier than financial returns, which take years to appear. Reviewed quarterly by the CEO, they signal that the pathway is a management priority, not a side project for the venture team.

Corporate investors play an unusually prominent role in Saudi Arabia. Arab News, citing MAGNiTT data, reported that Saudi Arabia had the highest ratio of corporate investors, with CVCs making up 30 percent of local unique investors. Saudi Aramco allocated an additional $4 billion to Aramco Ventures, increasing its total investment allocation from $3 billion to $7 billion, according to Gulf News.

The pattern differs from Silicon Valley. Gulf corporates are often large, state-linked or family-controlled, and may invest to build local ecosystems and technology capability as well as to earn returns. Their portfolios can combine venture investments with joint ventures, offtake agreements and industrial partnerships. For foreign startups, a corporate investor may be the route to a first customer, a licence or a localisation partner in the Kingdom. For corporates, it can accelerate the transfer of technology into domestic supply chains.

For a European or UK corporate, the implication is twofold. As an investor, a Gulf co-investor can bring market access, capital and credibility, and a joint structure may be more productive than a competing one. As a strategic partner, Gulf corporates seek technology and know-how, which makes a joint venture or licensing arrangement a plausible alternative to a conventional minority stake. Both routes require clear commercial terms and careful regulatory advice, including on foreign investment and data.

If you are considering Gulf co-investment, ask three questions. Which Gulf corporates have an interest in your technology or customers? What does each want beyond financial return, such as local manufacturing, training or a regional headquarters? And how will governance and information rights work across the partnership? Answering these before the first meeting separates serious discussions from courtesy calls. Work with qualified local advisers and, for UK promotions of investments, with FCA-authorised firms.

Foreign investment screening and data rules are increasingly relevant for cross-border corporate venturing. Governments in several regions have tightened scrutiny of investments in sensitive technologies, and partnerships that involve sharing data or intellectual property can trigger notifications or licensing requirements. These are matters for specialist counsel, but the strategic team should flag them early, because they affect structure, timing and which counterparties are realistic. Treat compliance as part of the commercial design.

Designing a CVC is a sequence of decisions, and the order matters. Start with strategic intent: the problems the corporation needs startups to help solve. Then the primary objective and scorecard. Then the structure: balance-sheet investments, a dedicated fund or a hybrid, and where the unit reports. Then the commercial pathway into business units. Then the team and capital. Finally the stop rules: the conditions under which the programme will shrink, pause or close. Each step constrains the next.

Capital should be committed in tranches linked to evidence. A common error is to approve a large fund up front and then discover that the commercial pathway does not work. A better approach commits an initial amount sufficient for a defined number of investments, with the next tranche released when the first cohort shows, for example, a minimum number of commercial pilots and a functioning governance process. This gives the CEO a decision to make, rather than a sunk commitment to defend.

For the head of strategy, stop rules are as important as start rules. Programmes that cannot be closed are rarely improved. Agree in advance what would cause a reduction or closure: no commercial adoption after three years, persistent conflict with business units, or a change in strategic priorities. Review at fixed dates. If a CVC has delivered insight and partnerships but not returns, the board may decide that is enough; if it has delivered neither, the decision should be made quickly.

In the first 100 days, publish the strategic-intent statement and charter, appoint the investment committee, agree the scorecard, identify one sponsor per business unit, and map the procurement route. Choose two or three themes and a short list of target startups that business units would use. Make no investments until the pathway has been tested on an existing relationship. Where the programme will manage third-party capital or advise investors, engage regulatory counsel and FCA-authorised firms. Karter McKinley supports design and process; it does not provide regulated advice.

Finally, set a calendar. Put the six decisions in the order described, assign an owner and a date to each, and agree what the CEO and board will see at each point. The discipline of a plan with dates forces the real conversations early, such as which business unit will sponsor, who will fund the pilot budget and what the stop rules are. Programmes that skip these conversations usually have them later, under pressure, and on worse terms.

Karter McKinley's M&A & Corporate Development work helps corporates define the strategic intent of a venture programme, design governance and scorecards, and build the commercial pathway into business units, including partnership and acquisition options. We work alongside FCA-authorised firms where regulated activity is involved, and we do not provide investment advice.